Stocks of the Hour: NOVONIX, Cynata Therapeutics, Cauldron Energy
Stocks of the Hour: NOVONIX, Cynata Therapeutics, Cauldron Energy
To register for Friday's webinar click here.
請點擊此處註冊星期五的網絡研討會。
NOVONIX (ASX:NVX) and CBMM has joined forces to develop cost-effective, high-performance cathode materials. NOVONIX's patented process will combine with CBMM's niobium to create high-performance, low-cost batteries. Shares are trading 0.81 per cent lower at 61 cents.
NOVONIX(ASX:NVX)和CBMm聯手開發成本效益高、性能卓越的特斯拉-正極材料。NOVONIX的專利工藝將與CBMM的鈮相結合,創造出性能卓越、成本低廉的電池。股票交易價爲61美分,下跌0.81%。
Cynata Therapeutics (ASX:CYP) announces positive preclinical results for Cymerus therapy in pulmonary fibrosis. Cymerus MSCs demonstrated significant reversal of pulmonary fibrosis and lung stiffness in preclinical model. Shares are trading 2.56 per cent higher at 20 cents.
Cynata Therapeutics(ASX:CYP)宣佈Cymerus治療肺纖維化的臨床前積極結果。在臨床前模型中,Cymerus MSCs顯著逆轉了肺纖維化和肺部僵硬度。股票交易價爲20美分,上漲2.56%。
Cauldron Energy (ASX:CXU) confirms high-grade uranium mineralisation at Bennet Well. Infill drilling program successfully extends and confirms uranium palaeochannel, with plans to expand exploration footprint. Shares are trading flat at 1.9 cents.
Cauldron Energy(ASX:CXU)確認在Bennet Well發現高品位鈾礦化物質化。填充鑽探計劃成功擴展並證實鈾古水道,計劃擴大勘探範圍。股票交易價爲1.9美分,持平。